skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialoheptaosylceramide > alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer

اصطلاح مرجح

alpha-l-fuc-(1->3)-[beta-d-gal-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neuac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C61H100N4O45R1R2

نقشی دارد

جرم

  • 1609.449

جرم تک‌ایزوتوپی

  • 1608.56596

اسمایلٓ

  • [C@@H]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O[C@@H]3O[C@H]([C@H]([C@H]([C@@H]3O)O)O)C)NC(=O)C)O[C@@H]4[C@H]([C@@H](O[C@@H]([C@@H]4O)CO)O[C@@H]5[C@H]([C@@H](O[C@@H]([C@@H]5O)CO)O[C@@H]6[C@@H]([C@H]([C@@H](O[C@@H]6CO)O[C@H]7[C@@H]([C@H]([C@@H](O[C@@H]7CO)OC[C@@H]([C@@H](*)O)NC(=O)*)O)O)O)O[C@]8(O[C@]([C@@H]([C@H](C8)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C(O)=O)NC(=O)C)O

زیرمجموعه

  • 3_STAR

مترادف دقیق

  • 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-[6-deoxy-alpha-L-galactopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

مترادف مرتبط

  • 188C1 ganglioside
  • alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-[alpha-NeupAc-(2->3)]-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
  • Le(x)-GM1

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141336

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD